Veracyte, Inc.

60
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US92337F1075
USD
47.41
1.25 (2.71%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Veracyte, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
25.00
-76.00
-36.00
-81.00
-34.00
-12.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-21.00
-4.00
-16.00
4.00
0.00
-4.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
75.00
44.00
7.00
-31.00
-9.00
-3.00
Cash Flow from Investing Activities
-56.00
15.00
-29.00
-739.00
-3.00
-42.00
Cash Flow from Financing Activities
4.00
2.00
3.00
596.00
203.00
127.00
Net Cash Inflow / Outflow
23.00
62.00
-18.00
-176.00
190.00
81.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
-1.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Veracyte, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
25.744
-131.162
156.00
119.63%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-21.319
-4.3
-17.00
-395.79%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
75.096
-26.369
101.00
384.79%
Cash Flow from Investing Activities
-56.275
-140.242
84.00
59.87%
Cash Flow from Financing Activities
4.904
90.315
-86.00
-94.57%
Net Cash Inflow / Outflow
23.301
-76.47
99.00
130.47%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.424
-0.174
0.00
-143.68%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 69.82% vs 486.89% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
75.10
44.22
69.82%